Latest / Health News Today | 2 Min News | The Daily News Now!
FDA Approves First New ADHD Med in Years | Health and Fitness News
FDA just approved Simtriyo, a groundbreaking once-daily ADHD medication for kids as young as six, teens, and adults — the first to target dopamine, norepinephrine, and serotonin. Clinical trials showed rapid symptom relief in adults and significant improvement in teens and kids on higher doses. Side effects are typical for ADHD meds — mild to moderate — including appetite loss, nausea, and headaches. Especially promising for treatment-resistant cases or those with ADHD and anxiety, and may help kids struggling with weight gain from stimulants. Expected to launch later this year. Listen in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.